Diabetes duration is associated with increased thin-cap fibroatheroma detected by intravascular ultrasound with virtual histology

Circ Cardiovasc Interv. 2009 Dec;2(6):543-8. doi: 10.1161/CIRCINTERVENTIONS.109.876672. Epub 2009 Oct 13.

Abstract

Background: Coronary plaque classified as thin-cap fibroatheroma (TCFA) is believed to be associated with plaque rupture and coronary heart disease-related events. Although an association between duration of diabetes and increased coronary heart disease risk has been demonstrated, the relationship between TCFA and diabetes duration is unknown.

Methods and results: Prospective registry of diabetic patients undergoing diagnostic coronary angiography and intravascular ultrasound (IVUS) enrolled in a diabetic gene and biomarker banking registry. Plaque composition in the most diseased 10-mm segment of a single coronary artery was assessed using IVUS virtual histology and was classified by phenotype as IVUS-defined adaptive intimal thickening, pathological intimal thickening, TCFA, fibroatheroma, or fibrocalcific. Patients (n=54) were stratified by duration of diabetes (<10 or > or = 10 years). Patients with diabetes > or = 10 years were older, less likely to have a history of tobacco use, had higher total cholesterol levels, and were more likely to be treated with insulin compared with patients with diabetes <10 years. Longer duration of diabetes was associated with greater plaque burden in the most diseased 10-mm segment (60.4% [53.4% to 66.8%] versus 50.2% [47.7% to 58.4%], P=0.008). The proportion of IVUS-defined TCFA in the > or = 10-year group was greater than the <10-year group (54.4% [11.6% to 77.5%] versus 10.8% [0.0% to 26.1%], P=0.009). This association persisted after adjustment for multiple comparisons, clinical characteristics, and diabetes treatment.

Conclusions: In this cohort, longer duration of diabetes was associated with IVUS-defined TCFA, a plaque phenotype associated with risk of rupture and coronary heart disease events.

Clinical trial registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00428961.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Calcinosis / diagnostic imaging
  • Calcinosis / pathology
  • Cholesterol / blood
  • Coronary Angiography
  • Coronary Artery Disease / diagnostic imaging*
  • Coronary Artery Disease / etiology
  • Coronary Artery Disease / pathology
  • Coronary Vessels / diagnostic imaging*
  • Coronary Vessels / pathology
  • Diabetes Mellitus / diagnostic imaging*
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus / pathology
  • Diabetic Angiopathies / diagnostic imaging*
  • Diabetic Angiopathies / etiology
  • Diabetic Angiopathies / pathology
  • Female
  • Fibrosis
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin / therapeutic use
  • Male
  • Middle Aged
  • Phenotype
  • Predictive Value of Tests
  • Prospective Studies
  • Registries
  • Reproducibility of Results
  • Risk Assessment
  • Risk Factors
  • Rupture
  • Severity of Illness Index
  • Smoking / adverse effects
  • Time Factors
  • Tunica Intima / diagnostic imaging
  • Tunica Intima / pathology
  • Ultrasonography, Interventional*

Substances

  • Hypoglycemic Agents
  • Insulin
  • Cholesterol

Associated data

  • ClinicalTrials.gov/NCT00428961